Adherence to In-Office Glaucoma Evaluation Appointment Clinical Trial
Official title:
Effectiveness of a Telehealth-Based Intervention to Detect and Manage Glaucoma Among High-Risk Populations in Community Health Settings (NYC-SIGHT-2)
Abundant evidence indicates that vision and eye health disparities exist due to a disproportionate eye disease burden among high-risk populations. Columbia University Department of Ophthalmology clinical researchers designed the New York City SIGHT Study (NYC-SIGHT-2) to evaluate Effectiveness of a Telehealth-Based Intervention to Detect and Manage Glaucoma Among High-Risk Populations in Community Health Settings in Upper Manhattan. The program begins with a telehealth-based eye health screening, optometric exam, eyeglasses, and referral to ophthalmology. The telehealth-based intervention uses patient navigators and peer ambassadors to improve eye care access, utilization, and adherence to in-office glaucoma evaluation appointment compared to Usual Care, while the study also explores the experiences of enrolled participants and program staff as well as cost-effectiveness of the intervention.
The investigators and an interdisciplinary team with experience in ophthalmology, optometry, biostatistics/data analysis, implementation science, mixed-methods epidemiology, and health outcomes/cost analysis designed NYC-SIGHT-2 to promote eye and vision health equity and address eye health disparities in adults. NYC-SIGHT-2 will be an innovative, comparative effectiveness study with a 2:1 cluster-randomized clinical trial enrolling primarily African American and Hispanic/Latino individuals with high rates of inadequate eye care. A total of 10 community health settings will be included to give access to 17,000 individuals at high-risk of eye disease. Clinical measures (visual acuity, intraocular pressure, fundus images, visual field test and contrast sensitivity), quality-of-life, and falls risk will be assessed. All participants referred to ophthalmology will receive assistance from a Patient Navigator with scheduling an initial in-office glaucoma evaluation appointment and motivational support from a Peer Ambassador (patient with glaucoma), who will calls 2x/year over 2 years. ;